基于CBCT的前列腺及盆腔淋巴结SABR的CTV-PTV外扩边界推导新方法
前列腺配准方案下,前列腺、前列腺+精囊腺及盆腔淋巴结分别需要5.2、6.5和7.6 mm的外扩边界,前列腺和精囊腺结构的外扩边界与传统方法吻合良好。
要点
- 前列腺配准方案下,前列腺、前列腺+精囊腺及盆腔淋巴结的CTV-PTV边界分别为5.2、6.5、7.6 mm。
- 该方法适用于单等中心多靶区SABR的边界推导。
- 前列腺和精囊腺结构的外扩边界与传统方法差异在±1.0 mm以内。
核心结论
- 提出了一种基于CBCT解剖数据的几何外扩边界推导方法,适用于单等中心多靶区SABR治疗。
主要发现
- 前列腺配准方案下,前列腺、前列腺+精囊腺及盆腔淋巴结的CTV-PTV边界分别为5.2、6.5和7.6 mm。
- 前列腺和精囊腺结构的外扩边界与传统方法吻合良好,差异在±1.0 mm以内。
关键数值与推荐
- 外扩边界通过逐步扩大复合CTV结构直至达到95%重叠来确定。
临床怎么用
- 该结果已用于支持一项针对高危局限期前列腺癌患者的前列腺及盆腔淋巴结SABR的机构内试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatomical data. METHODS: Twenty patients with high-risk localized prostate cancer were selected for retrospective review. Individual volumes of interest (prostate, prostate and seminal vesicles and pelvic lymph nodes) were delineated on five representative CBCTs and registered to the planning CT using two registration protocols: bone match or prostate-based soft tissue match. Margins were incrementally expanded around composite CTV structures until 95% overlap was achieved. RESULTS: CTV-PTV margins of 5.2, 6.5 and 7.6 mm were required for prostate, prostate and seminal vesicles and pelvic lymph nodes respectively using a prostate matching protocol. For the prostate and seminal vesicle structures, margins calculated using our method displayed good agreement with a conventional margin recipe (within ±1.0 mm). CONCLUSIONS: We have presented an alternative method of CTV-PTV margin derivation that is applicable to SABR treatments with more than one isocentric target. These results have informed an institutional trial of prostate and pelvic nodal SABR in men with high-risk localized prostate cancer.
引用
- Lyons CA, King RB, Osman SOS, et al. A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy. Radiat Oncol. 2017. PMID: 28778178. doi:10.1186/s13014-017-0859-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。